London, UK, 18th January 2017 / Sciad Newswire / Biotech and Money London 2017, a C-level executive conference that helps build linkages and business opportunities for UK and European life science companies taking place on 7-8 February 2017, has added a Medtech and Money Day to help medtech executives, investors and pharma access high-value collaboration opportunities.
Due to unprecedented demand from the Biotech and Money community, the conference is presenting sessions for major medtech heads to promote their external partnering and business development opportunities. The event will also see CEOs from the UK and Europe’s most progressive medtech and device companies taking to the podium to pitch their companies and technologies to qualified investors and pharma BD&L heads.
Companies already signed up to participate in the Medtech and Money Day include Lilly, Calcivis, GNA Biosolutions, Jupiter Diagnostics, AgPlus Diagnostics, Oxford Impedance Diagnostics, Qbtech, Momentum Bioscience and Sentinel Oncology.
The 3rd annual Biotech and Money London conference, hosted together with prominent partners EY, Cocoon Networks, Lilly, Nasdaq, JAG Shaw Baker, CMS Cameron McKenna and Catapult Medicines Discovery, will bring together over 400 of the finest names in the sector to discuss the strategies to successfully raise finance and investment, the means to building a strong and sustainable capital market in the UK and Europe, and the opportunities around building long term partnerships and collaborations with the industry’s key players.
With a focus on quality peer-2-peer discussion, high level networking and partnering, unique formats and a vetted, high calibre audience, the event attracts the people that matter to the future of life science investment and deal making.
Terry O’Dwyer, Co-CEO, Biotech and Money, said: “Recognising that funding and investment are only one piece of the puzzle for life science companies, adding the Medtech and Money Day allows innovative UK and European medtech companies to hear from and meet prospective partners and maximise their chances of deal making. We’re excited for the dynamic this will create alongside our traditional, and highly successful, investment content on day one.”
To view the full event programme and register, please visit www.biotechandmoney.com/london or call +44 (0) 203 637 5908 etx 201. Alternatively, keep up to date with the event on Twitter @BiotechandMoney or using #BMLDN17.
ENDS
For further information, contact:
Biotech and Money
Lea Bidiville, Marketing Executive
E: lea@biotechandmoney.com
T: +44 (0) 203 637 5908 ext 203.
Sciad Communications, Media Relations
Emma Pickup, Account Executive
E: emma@sciad.com
T: +44 (0)20 7470 8801
Notes to Editors
About Biotech and Money London
The Biotech and Money London 2017 conference takes place on 7-8 February 2017 at etc.Venues in London. The event is a two-day congress providing the education, strategies and solutions life science companies need to enable more effective funding, investment, business planning and partnering within their businesses. The conference is co-located with HealthEx London, an invite only closed door Chatham House Rules Listed Forum for CEOs, CFOs, Chairmen and NEDs of publicly listed companies. Visit www.biotechandmoney.com/london .
About Biotech and Money
Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion dollar healthcare business. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Visit www.biotechandmoney.com